Skip to main content Help with accessibility Skip to main navigation

UPADACITINIB prolonged-release tablets (RINVOQ®▼) for treating ulcerative colitis

CCG Approval Status:

Date Added: 26 - Sep - 2022
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of UPADACITINIB prolonged-release tablets (RINVOQ®▼) for treating ulcerative colitis.